This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Capomolla, S. Articles by Cobelli, F. Search for Related Content PubMed PubMed Citation Articles by Capomolla, S. Articles by Cobelli, F.

Echo-Doppler mitral flow monitoring: an operative tool to evaluate day-to-day tolerance to and effectiveness of beta-adrenergic blocking agent therapy in patients with chronic heart failure

^a Fondazione "Salvatore Maugeri," Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Scientifico di Montescano, Pavia, Italy

View larger version (28K): [in a new window]   Figure 1 Schematic diagram of the titration profile of the patients enrolled in the study according to baseline mitral flow pattern (MFP) and its acute change after loading manipulations. NTP = nitroprusside infusion; PLL = passive leg lifting.

View larger version (22K): [in a new window]   Figure 2 Kaplan-Meier survival curves for the combined end point of cardiac mortality or urgent heart transplantation or readmission for congestive heart failure. Patients were stratified according to the chronic change of the mitral flow pattern after six months of beta-adrenergic blocking agent treatment. MFP = mitral flow pattern.